Pathware
PrivateLast Round
Series A
Apr 19, 2022
Total Funding Raised
$8.46M
Company Overview
Pathware operates in Healthcare & Life Sciences and is based in Golden, Colorado. Its latest recorded funding round was a Series A round in April 2022.
Pathware is a medical technology company that has developed a digital pathology platform intended for point-of-care diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Medical AI
Business Model
B2B
Customer Profile
Hardware + Subscription, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pathware Comparables
Compare Pathware with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Instapath Inc. | 84% | |
| OptraSCAN | 78% | |
| Techcyte, Inc. | 76% |
For institutional investors. Book with your work email.
Pathware Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 19, 2022 | ||||
| Seed | Sep 9, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pathware Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UnityPoint Health Ventures | Series A |
| Level Eight Ventures | Series A |
| University of Washington | Seed |
| National Science Foundation | Grant |
| Solas BioVentures | Series A |
| MVolution Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 23, 2026
Grew 25% QoQ, from 12 to 15 employees.
- Apr 19, 2022
$7M round led by UnityPoint Health Ventures and Level Eight Ventures.
For institutional investors. Book with your work email.
Pathware Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pathware's valuation, stock price, and market status.
Is Pathware a public or private company?
Pathware is a private company.
What is the current stock price of Pathware?
Pathware is a private company, so its shares have no public market price. Caplight tracks Pathware's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pathware worth (valuation)?
Valuation information for Pathware is not publicly available.
Can I buy Pathware stock?
Pathware shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pathware's last funding round?
Pathware's most recent funding round was Series A on April 19, 2022.
Who are the main investors in Pathware?
Key investors in Pathware include UnityPoint Health Ventures, Level Eight Ventures, National Science Foundation.
Will Pathware IPO soon?
No public IPO plans have been announced for Pathware.
How can I track Pathware secondary market activity?
Caplight tracks bids, offers, and trades in Pathware's shares on secondary markets.